StockData
Vericel Corp logo

Vericel Corp (VCEL) stock

VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)

Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –

Vericel pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Vericel's pe ratio was 141.6× on Nov 11, 2026, against 211.8× a year earlier. Over the last 3 years it ranged from 90.1× to 925.8×, with a median of 256.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026141.6×−48.0
2025Dec 31, 2025189.5×−594.9
2024Dec 31, 2024784.4×+528.8
2021Oct 29, 2021255.7×–

More Vericel figures

See a number that looks wrong?